Cathay Biotech Inc.’s Net Profit Rose 6.4% in First Three Quarters of 2022

Cathay Biotech Inc. (上海凯赛生物技术股份有限公司) (688065.SH) reported a net profit of 530.8 million yuan in the first three quarters of 2022, up 6.4% year-on-year.

Meanwhile, the company posted 1.8 billion yuan in revenue, up 4.8% year-on-year.

At the end of the reporting period, it had 17.3 billion yuan in total assets and 2.3 billion yuan in total liabilities, with a liability-to-asset ratio of 13.5%.